116 related articles for article (PubMed ID: 11997665)
21. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs.
Jabłońska-Trypuć A; Matejczyk M; Rosochacki S
J Enzyme Inhib Med Chem; 2016; 31(sup1):177-183. PubMed ID: 27028474
[TBL] [Abstract][Full Text] [Related]
22. Raloxifene inhibits matrix metalloproteinases expression and activity in macrophages and smooth muscle cells.
Bellosta S; Baetta R; Canavesi M; Comparato C; Granata A; Monetti M; Cairoli F; Eberini I; Puglisi L; Corsini A
Pharmacol Res; 2007 Aug; 56(2):160-7. PubMed ID: 17582780
[TBL] [Abstract][Full Text] [Related]
23. Organ heterogeneity of host-derived matrix metalloproteinase expression and its involvement in multiple-organ metastasis by lung cancer cell lines.
Shiraga M; Yano S; Yamamoto A; Ogawa H; Goto H; Miki T; Miki K; Zhang H; Sone S
Cancer Res; 2002 Oct; 62(20):5967-73. PubMed ID: 12384564
[TBL] [Abstract][Full Text] [Related]
24. Induction of tumour cell apoptosis by matrix metalloproteinase inhibitors: new tricks from a (not so) old drug.
Mitsiades N; Poulaki V; Mitsiades CS; Anderson KC
Expert Opin Investig Drugs; 2001 Jun; 10(6):1075-84. PubMed ID: 11772236
[TBL] [Abstract][Full Text] [Related]
25. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinase inhibition facilitates cell death in intracerebral hemorrhage in mouse.
Grossetete M; Rosenberg GA
J Cereb Blood Flow Metab; 2008 Apr; 28(4):752-63. PubMed ID: 17971790
[TBL] [Abstract][Full Text] [Related]
27. Imatinib-associated matrix metalloproteinase suppression in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.
Umbreit C; Aderhold C; Faber A; Sauter A; Hofheinz RD; Stern-Straeter J; Hoermann K; Schultz JD
Oncol Rep; 2014 Aug; 32(2):668-76. PubMed ID: 24890748
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of matrix metalloproteinases mediates thromboxane A2-induced invasion in lung cancer cells.
Li X; Tai HH
Curr Cancer Drug Targets; 2012 Jul; 12(6):703-15. PubMed ID: 22515524
[TBL] [Abstract][Full Text] [Related]
29. The effect of cyclodextrins on the aqueous solubility of a new MMP inhibitor: phase solubility, 1 H-NMR spectroscopy and molecular modeling studies, preparation and stability study of nebulizable solutions.
Bertholet P; Gueders M; Dive G; Albert A; Barillaro V; Perly B; Cataldo D; Piel G; Delattre L; Evrard B
J Pharm Pharm Sci; 2005 Jul; 8(2):163-74. PubMed ID: 16124927
[TBL] [Abstract][Full Text] [Related]
30. Synthetic matrix metalloproteinase inhibitors and tissue inhibitor of metalloproteinase (TIMP)-2, but not TIMP-1, inhibit shedding of tumor necrosis factor-alpha receptors in a human colon adenocarcinoma (Colo 205) cell line.
Lombard MA; Wallace TL; Kubicek MF; Petzold GL; Mitchell MA; Hendges SK; Wilks JW
Cancer Res; 1998 Sep; 58(17):4001-7. PubMed ID: 9731514
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of the insulin-like growth factor-1 receptor potentiates acute effects of castration in a rat model for prostate cancer growth in bone.
Nordstrand A; Bergström SH; Thysell E; Bovinder-Ylitalo E; Lerner UH; Widmark A; Bergh A; Wikström P
Clin Exp Metastasis; 2017 Apr; 34(3-4):261-271. PubMed ID: 28447314
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic study of a new synthetic MMP inhibitor (Ro 28-2653) after IV and oral administration of cyclodextrin solutions.
Piette M; Evrard B; Frankenne F; Chiap P; Bertholet P; Castagne D; Foidart JM; Delattre L; Piel G
Eur J Pharm Sci; 2006 Jun; 28(3):189-95. PubMed ID: 16520026
[TBL] [Abstract][Full Text] [Related]
33. Effect of matrix metalloproteinase inhibitors on rat embryo development in vitro.
Del Bigio MR; Seyoum G
Cells Tissues Organs; 1999; 165(2):67-73. PubMed ID: 10516419
[TBL] [Abstract][Full Text] [Related]
34. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.
Merdad A; Karim S; Schulten HJ; Dallol A; Buhmeida A; Al-Thubaity F; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
Anticancer Res; 2014 Mar; 34(3):1355-66. PubMed ID: 24596383
[TBL] [Abstract][Full Text] [Related]
35. Synthetic inhibitor of matrix metalloproteases decreases tumor growth and metastases in a syngeneic model of rat prostate cancer in vivo.
Rabbani SA; Harakidas P; Guo Y; Steinman D; Davidsen SK; Morgan DW
Int J Cancer; 2000 Jul; 87(2):276-82. PubMed ID: 10861487
[TBL] [Abstract][Full Text] [Related]
36. Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate.
Jourquin J; Tremblay E; Décanis N; Charton G; Hanessian S; Chollet AM; Le Diguardher T; Khrestchatisky M; Rivera S
Eur J Neurosci; 2003 Sep; 18(6):1507-17. PubMed ID: 14511330
[TBL] [Abstract][Full Text] [Related]
37. New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9.
Lee CS; Kwon YW; Yang HM; Kim SH; Kim TY; Hur J; Park KW; Cho HJ; Kang HJ; Park YB; Kim HS
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):472-9. PubMed ID: 19201691
[TBL] [Abstract][Full Text] [Related]
38. Quest for selectivity in inhibition of matrix metalloproteinases.
Brown S; Meroueh SO; Fridman R; Mobashery S
Curr Top Med Chem; 2004; 4(12):1227-38. PubMed ID: 15320723
[TBL] [Abstract][Full Text] [Related]
39. Dosing and scheduling influence the antitumor efficacy of a phosphinic peptide inhibitor of matrix metalloproteinases.
Dive V; Andarawewa KL; Boulay A; Matziari M; Beau F; Guerin E; Rousseau B; Yiotakis A; Rio MC
Int J Cancer; 2005 Feb; 113(5):775-81. PubMed ID: 15499617
[TBL] [Abstract][Full Text] [Related]
40. Infiltrative capacity of T leukemia cell lines: a distinct functional property coupled to expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinases-1 (TIMP-1).
Ivanoff A; Ivanoff J; Hultenby K; Sundqvist KG
Clin Exp Metastasis; 1999; 17(8):695-711. PubMed ID: 10919715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
